Tue, Aug 13, 2024
Alembic Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) to market Dabigatran Etexilate Capsules (110 mg), a generic product for the prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery. This product is therapeutically equivalent to Boehringer Ingelheim's Pradaxa Capsules. With this approval, Alembic now has a total of 211 ANDA approvals from the USFDA. Shares of Alembic Pharmaceuticals closed 3.17% lower at Rs 1,076 apiece on the BSE
More >
Mon, Jul 15, 2024
Zomato, Lupine, Alembic Pharmaceuticals & Rail Vikas Nigam, which stocks will be in focus today? News shares and triggers. Know about Stocks In News.
Tue, Aug 22, 2023
As per the US health regulator's latest Enforcement Report, the US-based subsidiary of Alembic Pharmaceuticals is recalling 82,400 bottles of Tobramycin Ophthalmic Solution in the American market.
Fri, Aug 04, 2023
Alembic Pharmaceuticals, based in New Delhi, released its financial report for the first quarter
Mon, Mar 27, 2023
VRL Logistics, Sun Pharmaceutical Industries, One 97 Communications (the parent of digital payments company Paytm) and Alembic Pharmaceuticals among others are in focus on the back of either stock-related news or various corporate actions on Monday, March 27, 2023.
Thu, Mar 09, 2023
Alembic Pharmaceuticals on Thursday said it has received an approval from the US health regulator to market a generic antidepressant medication in the American market.
Fri, Mar 03, 2023
Shares of Alembic Pharmaceuticals Ltd. declined to their 52-week low after the company said it will take a Rs 1,150.43 crore impairment charge for three facilities in Gujarat. How is the financial status of Alembic Pharma? Know the complete details from Nupur.
Fri, Feb 03, 2023
Alembic Pharma: Q3 profit down 30% to ₹121 Cr. What are the reasons for the fall in margin? What is the plan ahead regarding growth? Watch Anil Singhvi's exclusive conversation with Pranav Amin, MD, Alembic Pharmaceuticals.
Mon, May 02, 2022
Q4 Results 2022: Companies which declared their results included Jindal Stainless Ltd, Alembic Pharma, Mahindra Holidays and TARC Ltd. Here are key highlights of the results
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
